On February 15, 2021 Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, reported that Aoife Brennan, M.B. Ch.B., Synlogic’s President and Chief Executive Officer, and other members of the executive team will present at the following virtual banking and industry conferences (Press release, Synlogic, FEB 15, 2021, View Source [SID1234575069]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BIO CEO & Investor Digital Conference: Dr. Brennan will have an on-demand presentation starting on Tuesday, February 16, 2021.
Cantor Fitzgerald Industry Panel: Dr. Brennan will present at 10:00 am on Thursday, February 18, 2021.
SVB Leerink 10th Annual Global Healthcare Conference: The Company will present at 5:00 pm on Thursday, February 25, 2021.
Cowen 41st Annual Health Care Conference: The Company will present at 9:10 am on Thursday, March 4, 2021.
H.C. Wainwright Global Life Sciences Conference: The Company will present at 4:00 pm on Tuesday, March 2, 2021.
Chardan’s 3rd Annual Microbiome Medicines Summit: The Company will present at 1:30 pm on Monday, March 8, 2021.
These are virtual events. A live webcast of the presentations, if available, can be accessed under "Event Calendar" in the Investors & Media section of the Company’s website. An archived copy of the webcast will be available on the Synlogic website for approximately 30 days after the event.